 Subjects included in the clinical study will be evaluated at screening, on enrolment into the study baseline and during the 12-week treatment programme at 4 and 12 weeks. A telephone call will be made at 1 week to check on the patients progress. In addition, subjects will be evaluated at 26 week following their commencement of the treatment. 